Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-06

Clinical Trial Update: Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating mesenchymal stem cells modified with chemokine and co-stimulatory molecules for advanced colorectal cancer, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemokine and co-stimulatory molecule-modified mesenchymal stem cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Advanced Colorectal Cancer | EARLY_Phase 1 | Status: RECRUITING